Citigroup Maintains Neutral on Pfizer, Raises Price Target to $27

Benzinga Newsdesk www.benzinga.com Positive 51.4%

Neg 0% Neu 0% Pos 51.4%

Citigroup analyst Geoff Meacham maintains Pfizer (NYSE:PFE) with a Neutral and raises the price target from $26 to $27.

Comments

No comments yet. Be the first!